These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16060980)

  • 1. Endothelial cells organize fibrin clots into structures that are more resistant to lysis.
    Jerome WG; Handt S; Hantgan RR
    Microsc Microanal; 2005 Jun; 11(3):268-77. PubMed ID: 16060980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clot lysis mediated by cultured human microvascular endothelial cells.
    Speiser W; Anders E; Binder BR; Müller-Berghaus G
    Thromb Haemost; 1988 Dec; 60(3):463-7. PubMed ID: 3149047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
    Undas A; Kolarz M; Kopeć G; Tracz W
    Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
    Wootton DM; Popel AS; Alevriadou BR
    Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets and endothelial cells act in concert to delay thrombolysis--evidence from an in vitro model of the human occlusive thrombus.
    Hantgan RR; Jerome WG; Handt S
    Thromb Haemost; 1998 Mar; 79(3):602-8. PubMed ID: 9531049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fibroblasts in organization and degradation of a fibrin clot.
    Mirshahi M; Azzarone B; Soria J; Mirshahi F; Soria C
    J Lab Clin Med; 1991 Apr; 117(4):274-81. PubMed ID: 2010668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells.
    Patterson AM; Ford I; Graham A; Booth NA; Greaves M
    Br J Haematol; 2006 May; 133(3):323-30. PubMed ID: 16643435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased von Willebrand factor, P-selectin and fibrin content in occlusive thrombus resistant to lytic therapy.
    Sambola A; García Del Blanco B; Ruiz-Meana M; Francisco J; Barrabés JA; Figueras J; Bañeras J; Otaegui I; Rojas A; Vilardosa Ú; Montaner J; García-Dorado D
    Thromb Haemost; 2016 Jun; 115(6):1129-37. PubMed ID: 26962963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
    Wu JH; Siddiqui K; Diamond SL
    Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of flow on lysis of plasma clots in a plasma environment.
    Sakharov DV; Rijken DC
    Thromb Haemost; 2000 Mar; 83(3):469-74. PubMed ID: 10744155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomeric C-reactive protein alters fibrin clot properties on endothelial cells.
    Li R; Ren M; Luo M; Chen N; Zhang Z; Luo B; Wu J
    Thromb Res; 2012 May; 129(5):e251-6. PubMed ID: 22475312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
    Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of homocysteine on fibrin network lysis.
    Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased retraction of fibrin clots by endothelial cells of infants of diabetic mothers.
    Nappi C; Cerbone AM; Papa R; Di Minno G; Cortese A; Farace MS; Turco S; Montemagno U; Mancini M
    Biol Res Pregnancy Perinatol; 1985; 6(3):141-2. PubMed ID: 3834950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F; Kani S; Hongo M; Okumura N
    Thromb Res; 2006; 118(5):651-61. PubMed ID: 16412498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.